Wu J - Search Results

1

Development of N-hydroxybenzamide derivatives with indole-containing cap group as histone deacetylases inhibitors.

Li X, Wu J, Li X, Mu W, Liu X, Jin Y, Xu W, Zhang Y. Li X, et al. Among authors: wu j. Bioorg Med Chem. 2015 Oct 1;23(19):6258-70. doi: 10.1016/j.bmc.2015.08.040. Epub 2015 Aug 29. Bioorg Med Chem. 2015. PMID: 26349626

2

Synthesis of novel derivatives of 4-amino-3-(2-furyl)-5-mercapto-1,2,4-triazole as potential HIV-1 NNRTIs.

Wu J, Liu X, Cheng X, Cao Y, Wang D, Li Z, Xu W, Pannecouque C, Witvrouw M, De Clercq E. Wu J, et al. Molecules. 2007 Aug 22;12(8):2003-16. doi: 10.3390/12082003. Molecules. 2007. PMID: 17960101 Free PMC article.

3

Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways.

Li Q, Wu J, Zheng H, Liu K, Guo TL, Liu Y, Eblen ST, Grant S, Zhang S. Li Q, et al. Among authors: wu j. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4526-30. doi: 10.1016/j.bmcl.2010.06.030. Epub 2010 Jun 8. Bioorg Med Chem Lett. 2010. PMID: 20580230

4

Recent advances in the DABOs family as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

Yu M, Fan E, Wu J, Liu X. Yu M, et al. Among authors: wu j. Curr Med Chem. 2011;18(16):2376-85. doi: 10.2174/092986711795843209. Curr Med Chem. 2011. PMID: 21568919 Review.

5

Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

Zhang J, Zhan P, Wu J, Li Z, Jiang Y, Ge W, Pannecouque C, De Clercq E, Liu X. Zhang J, et al. Among authors: wu j. Bioorg Med Chem. 2011 Jul 15;19(14):4366-76. doi: 10.1016/j.bmc.2011.05.024. Epub 2011 May 23. Bioorg Med Chem. 2011. PMID: 21683601

6

Design, synthesis, and biological characterization of tamibarotene analogs as anticancer agents.

Jiang Y, Li X, Wang X, Wang Z, Zhang J, Wu J, Xu W. Jiang Y, et al. Among authors: wu j. Chem Biol Drug Des. 2016 Oct;88(4):542-55. doi: 10.1111/cbdd.12778. Epub 2016 Jun 1. Chem Biol Drug Des. 2016. PMID: 27113097

7

Design, synthesis, and preliminary bioactivity evaluation of N¹ -hydroxyterephthalamide derivatives with indole cap as novel histone deacetylase inhibitors.

Wang X, Li X, Li J, Hou J, Qu Y, Yu C, He F, Xu W, Wu J. Wang X, et al. Among authors: wu j. Chem Biol Drug Des. 2017 Jan;89(1):38-46. doi: 10.1111/cbdd.12819. Epub 2016 Oct 26. Chem Biol Drug Des. 2017. PMID: 27416889

8

Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity.

Jiang Y, Hou J, Li X, Huang Y, Wang X, Wu J, Zhang J, Xu W, Zhang Y. Jiang Y, et al. Among authors: wu j. Bioorg Med Chem. 2016 Nov 15;24(22):5787-5795. doi: 10.1016/j.bmc.2016.09.033. Epub 2016 Sep 14. Bioorg Med Chem. 2016. PMID: 27670098

9

Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity study.

Li X, Zhang Y, Jiang Y, Wu J, Inks ES, Chou CJ, Gao S, Hou J, Ding Q, Li J, Wang X, Huang Y, Xu W. Li X, et al. Among authors: wu j. Eur J Med Chem. 2017 Jul 7;134:185-206. doi: 10.1016/j.ejmech.2017.03.069. Epub 2017 Mar 30. Eur J Med Chem. 2017. PMID: 28415009 Free PMC article.

10

Design, synthesis and tumor cell growth inhibitory activity of 3-nitro-2H-cheromene derivatives as histone deacetylaes inhibitors.

Tan S, He F, Kong T, Wu J, Liu Z. Tan S, et al. Among authors: wu j. Bioorg Med Chem. 2017 Aug 1;25(15):4123-4132. doi: 10.1016/j.bmc.2017.05.062. Epub 2017 Jun 1. Bioorg Med Chem. 2017. PMID: 28629630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78,092 results

Search Page

Filters